CoverageForm 410-K10-Q8-K13D13G13F

ISRG Intuitive Surgical Inc - 8-K

Filed May 28, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001035267-26-000042
5.029.01

Item 5.02 - Departure/Election of Directors or Certain Officers

101 words

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Senior Vice President of Global Business Operations of the Company.

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer. A copy of the Company’s press release is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01 - Financial Statements and Exhibits

35 words

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description.

99.1

Press release issued by Intuitive Surgical, Inc., dated May 28, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).